|
Nov 29, 2024
|
|
|
|
USC Catalogue 2016-2017 [ARCHIVED CATALOGUE]
|
RSCI 533 Safety Evaluation during Drug Development Units: 3 Safety pharmacology/toxicology requirements mandated by FDA and other regulatory agencies to move a new chemical entity from discovery stage to market approval. Instruction Mode: Lecture Grading Option: Letter
|
|
You must be logged in to post a comment.